October 1, 1989American Journal of Psychiatry

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

View Full Paper

Ask AI

Bookmark

Authors

MJM A JenikeHarvard University LBLee BaerHarvard University PSPaul SummergradTufts University

Abstract

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jenike et al. (1989) studied this question.

synapsesocial.com/papers/6ab5cf34c21d028cecfb7e82 https://doi.org/10.1176/ajp.146.10.1328

View Full Paper

Ask AI

Bookmark

Abstract

Clomipramine was significantly superior to placebo in a 10-week double-blind, placebo-controlled trial in 27 outpatients who met DSM-III-R criteria for obsessive-compulsive disorder.

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

Abstract

Discussion

Cite This Study

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

Abstract

Discussion

Cite This Study

Also Consider

Also Consider